CILOSTAZOL for Peripheral arterial occlusive disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 94 adverse event reports in the FDA FAERS database where CILOSTAZOL was used for Peripheral arterial occlusive disease.
Most Reported Side Effects for CILOSTAZOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 63 | 4.3% | 63 | 13 |
| Headache | 58 | 3.9% | 5 | 16 |
| Off label use | 56 | 3.8% | 4 | 28 |
| Gastrointestinal haemorrhage | 52 | 3.5% | 1 | 44 |
| Dizziness | 48 | 3.3% | 4 | 21 |
| Drug ineffective | 45 | 3.1% | 1 | 28 |
| Hypotension | 42 | 2.9% | 17 | 26 |
| Diarrhoea | 41 | 2.8% | 10 | 18 |
| Atrial fibrillation | 40 | 2.7% | 6 | 27 |
| Anaemia | 39 | 2.6% | 2 | 24 |
| Nausea | 39 | 2.6% | 10 | 25 |
| Vomiting | 38 | 2.6% | 8 | 20 |
| Tachycardia | 37 | 2.5% | 2 | 16 |
| Asthenia | 35 | 2.4% | 7 | 20 |
| Cerebral infarction | 35 | 2.4% | 6 | 23 |
Other Indications for CILOSTAZOL
Product used for unknown indication (441)
Cerebral infarction (154)
Intermittent claudication (70)
Antiplatelet therapy (53)
Ischaemic stroke (41)
Prophylaxis (28)
Cerebrovascular accident prophylaxis (27)
Peripheral vascular disorder (24)
Thrombosis prophylaxis (20)
Anticoagulant therapy (18)
Other Drugs Used for Peripheral arterial occlusive disease
RIVAROXABAN (761)
CLOPIDOGREL BISULFATE (700)
ASPIRIN (657)
TICAGRELOR (89)
ASPIRIN DL-LYSINE (72)
EVOLOCUMAB (58)
APIXABAN (55)
ATORVASTATIN (55)
UNSPECIFIED INGREDIENT (50)
VORAPAXAR (30)